Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Immunomedics, Inc. (IMMU)

« Back to company index

IMMU Chatter Timeline

Stock Ticker for IMMU

Most Active Tweeters for IMMU

UserTweets
@stockmktgenius 7
@IncredibleTrade 5
@TheMarketsDaily 5
@whatsonthorold2 5
@AmericanBanking 5

Recent Tweets for IMMU

Ronbtc79 @Ronbtc79
RT @BioStocks: $IMMU FDA Accepts BLA and Grants Priority Review for Sacituzumab Govitecan for the Treatment of Metastatic Triple-negative B…
July 18th 2018, 11:07pm
AndyBradley93 @AndyBradley93
@adamfeuerstein $IMMU How bout them Apples, Adam?!?!
July 18th 2018, 9:07pm
sububoston @sububoston
RT @Gupta_Calling: $IMMU FDA’s review of cancer drugs https://t.co/syd8xNiJeC New pilots to make development & review of cancer drugs mor…
July 18th 2018, 9:07pm
Gupta_Calling @Gupta_Calling
$IMMU FDA’s review of cancer drugs https://t.co/syd8xNiJeC New pilots to make development & review of cancer drug… https://t.co/hL4lrDiHUA
July 18th 2018, 8:07pm
ChartMill @ChartMill
$IMMU: Both the short term and long term trends are positive. This is a very positive sign. https://t.co/qXhbaK8e5a https://t.co/ZYidNNyg6M
July 18th 2018, 8:07pm
darock2399 @darock2399
$IMMU. Gapper play. Support 25.90's longed using vwap as a guide stopped out with slippage as she wasn't very liqui… https://t.co/Zdq3wBGPkc
July 18th 2018, 6:07pm
hotpennyalerts @hotpennyalerts
FDA accepts $IMMU ’s Biologics License Application for Filing and Grants Priority Review for Sacituzumab Govitecan… https://t.co/SCFyVXuHjZ
July 18th 2018, 6:07pm
dakotafinancial @dakotafinancial
Immunomedics $IMMU Sets New 52-Week High at $27.33 https://t.co/dPbM2BPC5q
July 18th 2018, 4:07pm
MareaInformativ @MareaInformativ
Immunomedics $IMMU Sets New 12-Month High at $27.33 https://t.co/Q1nPllHnws
July 18th 2018, 4:07pm
BioCentury @BioCentury
Priority Review for Immunomedics' ADC for triple-negative breast cancer https://t.co/v1I3FrxB1A $IMMU #breastcancer #tnbc
July 18th 2018, 4:07pm
Kevvy_Kaye @Kevvy_Kaye
RT @tgtxdough: Cowen $IMMU priority review signals the FDA's appreciation for the unmet need in TNBC, and we expect an approval and early 2…
July 18th 2018, 3:07pm
tgtxdough @tgtxdough
Cowen $IMMU priority review signals the FDA's appreciation for the unmet need in TNBC, and we expect an approval an… https://t.co/6OqLF4ytII
July 18th 2018, 3:07pm
mmahotstuff1 @mmahotstuff1
As Immunomedics INC $IMMU Valuation Rose, Venbio Select Advisor LLC Has Boosted by $224.90 Million Its Position - https://t.co/bvKiE6MpqA
July 18th 2018, 2:07pm
whatsonthorold2 @whatsonthorold2
Immunomedics INC $IMMU Holder Venbio Select Advisor LLC Raised Its Position - https://t.co/mzI3SqmxBH
July 18th 2018, 2:07pm
Fanob_stock @Fanob_stock
Venbio Select Advisor LLC Upped Position in Immunomedics INC $IMMU https://t.co/NLjgP0EZvl
July 18th 2018, 2:07pm
1MinuteStock @1MinuteStock
Wondering about risks of $IMMU? The 63-day volatility is 22.22% https://t.co/lPTAaTCTsN
July 18th 2018, 1:07pm
ConsumerFeed @ConsumerFeed
-$0.20 EPS Expected for Immunomedics, Inc. $IMMU This Quarter https://t.co/UUeFFv0wBT
July 18th 2018, 1:07pm
belle_aura @belle_aura
RT @bullishbrs: $IMMU 100% retracement complete, nice rising wedge pattern https://t.co/QfnWSzdMFs #stocks #biotech #momentum https://t.co/…
July 18th 2018, 11:07am
biostockinfo @biostockinfo
RT @odibro: $IMMU FDA Accepts BLA for Filing and Grants Priority Review for Sacituzumab Govitecan for the Treatment of Metastatic #TNBC. Pd…
July 18th 2018, 10:07am
Briefingcom @Briefingcom
$IMMU: Immunomedics: FDA has accepted its BLA for filing and granted Priority Review for sacituzumab govitecan for.… https://t.co/R0p13jtQ2d
July 18th 2018, 10:07am
TheUnicornBay @TheUnicornBay
Do you know that #WallStreet price for $IMMU is $14.17 https://t.co/JuPdmCJsJI
July 18th 2018, 9:07am
IncredibleTrade @IncredibleTrade
$IMMU worth watch for new highs in coming sessions .. Initial call around $20 .. https://t.co/v0B6BqECga
July 18th 2018, 9:07am
CNAFinance @CNAFinance
$IMMU heads up on regulatory update! https://t.co/U5BUT3JLtU
July 18th 2018, 9:07am
EXPstocktrader @EXPstocktrader
$IMMU you guys. Congrats on the YTD high again
July 18th 2018, 9:07am
BretKenwell @BretKenwell
Not too familiar with $IMMU, but some may find it worth watching https://t.co/a0mVRQPKOa
July 18th 2018, 9:07am
bullishbrs @bullishbrs
$IMMU 100% retracement complete, nice rising wedge pattern https://t.co/QfnWSzdMFs #stocks #biotech #momentum https://t.co/CdM1iJChaM
July 18th 2018, 9:07am
SwingTradeBot @SwingTradeBot
Recent $IMMU technical alerts: Bollinger Band Squeeze plus 3 more alerts... https://t.co/PigLDp8TNY
July 18th 2018, 9:07am
Stock_News_Now @Stock_News_Now
$IMMU: New SEC Filing for IMMU: Form 8-K (No. 0001104659-18-045646): https://t.co/ZhFQHFNZy4
July 18th 2018, 9:07am
MarketChmln @MarketChmln
$IMMU #ImmunomedicsInc. gains in premarket trading. See the latest news. https://t.co/lGaLTY85P9 https://t.co/VRt4TQN3C1
July 18th 2018, 9:07am
TimCarmichael3 @TimCarmichael3
$IMMU a great SMID cap continues to deliver---52 week high-- $30+ right around the corner https://t.co/Xmp4m5TJMt
July 18th 2018, 8:07am
sep_sal @sep_sal
RT @IncredibleTrade: $IMMU Immunomedics (IMMU) Reports FDA Acceptance of Biologics License Application for Filing and Granted Priority Revi…
July 18th 2018, 8:07am
pnani456 @pnani456
$IMMU D1 FDA news / indicated higher pre https://t.co/0eprtGQrJU
July 18th 2018, 8:07am
EXPstocktrader @EXPstocktrader
FDA accepts Immunomedics' BLA for sacituzumab govitecan for mTNBC; https://t.co/1Bp2Aeny01 $IMMU
July 18th 2018, 8:07am
MarketCurrents @MarketCurrents
FDA accepts Immunomedics' BLA for sacituzumab govitecan for mTNBC; shares up 2% premarket https://t.co/aQ7Y9OCh9z #premarket $IMMU
July 18th 2018, 8:07am
StockTexts @StockTexts
$IMMU Immunomedics, Inc. SEC Filing: Form 8-K https://t.co/4cCf7iCzR0
July 18th 2018, 8:07am
IncredibleTrade @IncredibleTrade
$IMMU Immunomedics (IMMU) Reports FDA Acceptance of Biologics License Application for Filing and Granted Priority R… https://t.co/Qp5WqEr7YZ
July 18th 2018, 8:07am
stockelite @stockelite
$IMMU FDA Accepts Biologics License Application for Filing and Grants Priority Review for Sacituzumab Govitecan for… https://t.co/nRmh0Ut7KW
July 18th 2018, 8:07am
BoerseGer @BoerseGer
$IMMU FDA Accepts Biologics License Application for Filing and Grants Priority Review for Sacituzumab Govitecan for… https://t.co/yJ1ZD8tpb3
July 18th 2018, 8:07am
odibro @odibro
$IMMU FDA Accepts BLA for Filing and Grants Priority Review for Sacituzumab Govitecan for the Treatment of Metastat… https://t.co/IK80Gg5snu
July 18th 2018, 8:07am
GNWLive @GNWLive
FDA Accepts Biologics License Application for Filing and Grants Priority Review for Sacituzumab Govitecan $IMMU https://t.co/kCi2xaDugP
July 18th 2018, 8:07am
BioStocks @BioStocks
$IMMU FDA Accepts BLA and Grants Priority Review for Sacituzumab Govitecan for the Treatment of Metastatic Triple-n… https://t.co/kDQ2lxbkhW
July 18th 2018, 8:07am
dispatchtribune @dispatchtribune
Brokerages Set Immunomedics, Inc. $IMMU Target Price at $31.50 https://t.co/JnoHvFjCeo
July 17th 2018, 9:07pm
OlympiaReport @OlympiaReport
Immunomedics, Inc. $IMMU Receives $31.50 Consensus Price Target from Analysts https://t.co/2ulbD62Uhf
July 17th 2018, 9:07pm
stockmktgenius @stockmktgenius
$IMMU Immunomedics, Inc. - Comm Top stock up 230% from low. Close: 25.40 VolvsAvg: 0.77 Liq: $31M https://t.co/YqoKLwtR2o
July 17th 2018, 8:07pm
TradeStockTrend @TradeStockTrend
$IMMU getting frisky (daily chart) https://t.co/kxUoJNQiIu
July 17th 2018, 3:07pm
mmahotstuff1 @mmahotstuff1
As Immunomedics INC $IMMU Market Value Rose, Shareholder Longwood Capital Partners LLC Has Lowered Its Stake - https://t.co/zZPEAcrXl1
July 17th 2018, 8:07am
whatsonthorold2 @whatsonthorold2
Immunomedics INC $IMMU Shareholder Longwood Capital Partners LLC Has Decreased Holding by $12.60 Million as Stock R… https://t.co/IBvOCbFd5v
July 17th 2018, 8:07am
stockmktgenius @stockmktgenius
$IMMU Immunomedics, Inc. - Comm Top stock up 230% from low. Close: 25.47 VolvsAvg: 0.72 Liq: $29M https://t.co/YqoKLwtR2o
July 16th 2018, 6:07pm
TheMarketsDaily @TheMarketsDaily
Immunomedics, Inc. $IMMU Expected to Announce Earnings of -$0.20 Per Share https://t.co/edwjQ8bNTD
July 16th 2018, 9:07am
dakotafinancial @dakotafinancial
Immunomedics $IMMU Rating Lowered to Sell at Zacks Investment Research https://t.co/apmaQFfzDI
July 16th 2018, 1:07am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.